mTOR folate sensing links folate availability to trophoblast cell function

Folate deficiency during pregnancy is associated with restricted fetal growth, although the underlying mechanisms are poorly understood. Here we show that mechanistic target of rapamycin (mTOR) functions as a folate sensor in primary human trophoblast (PHT) cells. Folate sensing by mTOR in PHT cells involves both mTOR Complex 1 and 2 and requires the proton‐coupled folate transporter. We report a previously unknown molecular mechanism by which folate regulates trophoblast cell function. Because mTOR is a positive regulator of placental amino acid transport and mitochondrial function, placental mTOR folate sensing may constitute the mechanistic link between maternal folate status and fetal growth. These findings provide new insight into how folate influences human cell physiology and may have implications for our understanding of how altered folate availability causes diseases such as fetal growth restriction, fetal malformations and cancer.

[1]  F. Rosario,et al.  Mechanistic target of rapamycin (mTOR) regulates trophoblast folate uptake by modulating the cell surface expression of FR-α and the RFC , 2016, Scientific Reports.

[2]  Y. Kanai,et al.  Regulation of amino acid transporter trafficking by mTORC1 in primary human trophoblast cells is mediated by the ubiquitin ligase Nedd4-2. , 2016, Clinical science.

[3]  F. Rosario,et al.  Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  F. Rosario,et al.  Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth , 2015, Proceedings of the National Academy of Sciences.

[5]  Madhulika B. Gupta,et al.  Increased ubiquitination and reduced plasma membrane trafficking of placental amino acid transporter SNAT-2 in human IUGR , 2015, Clinical science.

[6]  Verena Albert,et al.  mTOR signaling in cellular and organismal energetics. , 2015, Current opinion in cell biology.

[7]  D. Sabatini,et al.  Nutrient-sensing mechanisms and pathways , 2015, Nature.

[8]  Gregory A. Wyant,et al.  Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1 , 2015, Science.

[9]  K. Guan,et al.  Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.

[10]  Jonathan J. Wilde,et al.  Genetic, epigenetic, and environmental contributions to neural tube closure. , 2014, Annual review of genetics.

[11]  Guoyao Wu,et al.  Down‐regulation of placental mTOR, insulin/IGF‐I signaling, and nutrient transporters in response to maternal nutrient restriction in the baboon , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Michael N. Hall,et al.  Making new contacts: the mTOR network in metabolism and signalling crosstalk , 2014, Nature Reviews Molecular Cell Biology.

[13]  T. Powell,et al.  Role of Placental Nutrient Sensing in Developmental Programming , 2013, Clinical obstetrics and gynecology.

[14]  R. Steegers-Theunissen,et al.  Influence of maternal folate status on human fetal growth parameters. , 2013, Molecular nutrition & food research.

[15]  T. Powell,et al.  Oleic acid stimulates system A amino acid transport in primary human trophoblast cells mediated by toll-like receptor 4 , 2013, Journal of Lipid Research.

[16]  Y. Kanai,et al.  Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells , 2013, The Journal of physiology.

[17]  Xue Yu,et al.  Homocysteine Inhibits Hepatocyte Proliferation via Endoplasmic Reticulum Stress , 2013, PloS one.

[18]  F. Rosario,et al.  Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. , 2013, The Journal of clinical endocrinology and metabolism.

[19]  L. Matherly,et al.  The human proton-coupled folate transporter , 2012, Cancer biology & therapy.

[20]  D. Goberdhan,et al.  The emerging role of mTORC1 signaling in placental nutrient-sensing. , 2012, Placenta.

[21]  I. Cetin,et al.  Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation , 2012, Nutrition Journal.

[22]  Roberto Zoncu,et al.  Amino acids and mTORC1: from lysosomes to disease. , 2012, Trends in molecular medicine.

[23]  T. Powell,et al.  Placental transport in response to altered maternal nutrition , 2012, Journal of Developmental Origins of Health and Disease.

[24]  D. Goberdhan,et al.  Proton-Assisted Amino Acid Transporter PAT1 Complexes with Rag GTPases and Activates TORC1 on Late Endosomal and Lysosomal Membranes , 2012, PloS one.

[25]  D. Sabatini,et al.  A unifying model for mTORC1-mediated regulation of mRNA translation , 2012, Nature.

[26]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[27]  G. Thomas,et al.  Phospholipase D and mTORC1: Nutrients Are What Bring Them Together , 2012, Science Signaling.

[28]  S. Smeland,et al.  Cancer risk with folic acid supplements: a systematic review and meta-analysis , 2012, BMJ Open.

[29]  I. Goldman,et al.  Mechanisms of membrane transport of folates into cells and across epithelia. , 2011, Annual review of nutrition.

[30]  P. Nathanielsz,et al.  Fetal serum folate concentrations and placental folate transport in obese women. , 2011, American journal of obstetrics and gynecology.

[31]  Y. Kanai,et al.  Maternal Protein Restriction in the Rat Inhibits Placental Insulin, mTOR, and STAT3 Signaling and Down-Regulates Placental Amino Acid Transporters , 2011, Endocrinology.

[32]  S. Duthie Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis , 2011, Journal of Inherited Metabolic Disease.

[33]  D. Goberdhan,et al.  Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation , 2010, Oncogene.

[34]  D. Sabatini,et al.  Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.

[35]  H. Galan,et al.  Placental mammalian target of rapamycin and related signaling pathways in an ovine model of intrauterine growth restriction. , 2009, American journal of obstetrics and gynecology.

[36]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[37]  D. Alessi,et al.  New Insights into mTOR Signaling: mTORC2 and Beyond , 2009, Science Signaling.

[38]  Y. Kanai,et al.  Regulation of placental amino acid transporter activity by mammalian target of rapamycin. , 2009, American journal of physiology. Cell physiology.

[39]  D. Charnock-Jones,et al.  Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. , 2008, The American journal of pathology.

[40]  T. P. Neufeld,et al.  Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.

[41]  David M. Sabatini,et al.  The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.

[42]  M. Akabas,et al.  Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. , 2007, American journal of physiology. Cell physiology.

[43]  C. Ulrich Folate and cancer prevention: a closer look at a complex picture. , 2007, The American journal of clinical nutrition.

[44]  T. Powell,et al.  Mammalian target of rapamycin in the human placenta regulates leucine transport and is down‐regulated in restricted fetal growth , 2007, The Journal of physiology.

[45]  G. Thomas,et al.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.

[46]  G. Thomas,et al.  Nutrient sensing in the mTOR/S6K1 signalling pathway. , 2007, Biochemical Society transactions.

[47]  M. Akabas,et al.  Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption , 2006, Cell.

[48]  Gary M. Shaw,et al.  Neural tube defects and folate: case far from closed , 2006, Nature Reviews Neuroscience.

[49]  T. Tamura,et al.  Folate and human reproduction. , 2006, The American journal of clinical nutrition.

[50]  Roland N. Emokpae,et al.  Folate deficiency inhibits proliferation of adult hippocampal progenitors , 2005, Neuroreport.

[51]  M. Hall,et al.  The expanding TOR signaling network. , 2005, Current opinion in cell biology.

[52]  R. Wilkening,et al.  Placental uptake and transport of ACP, a neutral nonmetabolizable amino acid, in an ovine model of fetal growth restriction. , 2004, American journal of physiology. Endocrinology and metabolism.

[53]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[54]  P. Stover Physiology of folate and vitamin B12 in health and disease. , 2004, Nutrition reviews.

[55]  Michael N. Hall,et al.  TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.

[56]  T. Golub,et al.  The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation , 2002, Molecular and Cellular Biology.

[57]  Xuan Zheng,et al.  Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. , 2002, Blood.

[58]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[59]  Jeng Wei,et al.  Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells. , 1999, The Journal of nutrition.

[60]  M. de Swiet,et al.  Inherited thrombophilia and pregnancy. , 1998, Current opinion in obstetrics & gynecology.

[61]  R. Wilkening,et al.  Placental transport of threonine and its utilization in the normal and growth-restricted fetus. , 1997, The American journal of physiology.

[62]  J. C. Ross,et al.  Placental transport and fetal utilization of leucine in a model of fetal growth retardation. , 1996, The American journal of physiology.

[63]  D. Albanes,et al.  Folate and cancer: a review of the literature. , 1994, Nutrition and cancer.

[64]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[65]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[66]  R. Branda,et al.  Nutritional folate deficiency in chinese hamster ovary cells I. Characterization of the pleiotropic response and its modulation by nucleic acid precursors , 1989, Journal of cellular physiology.

[67]  H. Kliman,et al.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. , 1986, Endocrinology.

[68]  C. Schorah,et al.  Vitamin dificiencies and neural tube defects. , 1976, Archives of disease in childhood.

[69]  K. Rajalakshmi,et al.  Effect of folic acid supplement on birth weights of infants. , 1975, American journal of obstetrics and gynecology.

[70]  L. Iyengar,et al.  FOLIC ACID ABSORPTION IN PREGNANCY , 1975, British journal of obstetrics and gynaecology.